Publication | Open Access

Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndrome

Metabolic SyndromeMedicinal ChemistryHeterocyclicBiochemistryMedicineNatural SciencesNovel Therapeutic AgentsPharmacological AgentSelective InhibitorsPharmacotherapyHeterocycle ChemistryDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug Discovery